Vivos Therapeutics, Inc. ( (VVOS) ) has released its Q3 earnings. Here is a breakdown of the information Vivos Therapeutics, Inc. presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Vivos Therapeutics, Inc. is a medical technology and services company specializing in proprietary oral appliances and therapeutic treatments for sleep disorders, particularly obstructive sleep apnea (OSA). The company operates primarily in the healthcare sector, offering innovative non-surgical solutions for maxillofacial and developmental abnormalities associated with breathing and sleep disorders.
In its latest earnings report for the quarter ended September 30, 2025, Vivos Therapeutics highlighted a significant shift in its business model, focusing on strategic alliances and acquisitions to drive revenue growth. The company reported a notable increase in total revenue, driven by both product and service sales, despite facing a net loss for the period.
Key financial metrics revealed that Vivos Therapeutics achieved a total revenue of $6.8 million for the quarter, up from $3.9 million in the same period last year. This growth was primarily fueled by an increase in service revenue, which more than doubled compared to the previous year. However, the company reported a net loss of $5.4 million, reflecting increased operating expenses associated with its strategic pivot and recent acquisitions.
The company’s strategic shift included the acquisition of The Sleep Center of Nevada, marking a milestone in its new sales, marketing, and distribution model. This acquisition is expected to enhance Vivos’ ability to capture diagnostic and consulting revenues, alongside its traditional product sales, thereby creating new higher-margin revenue streams.
Looking ahead, Vivos Therapeutics remains focused on expanding its business model through additional acquisitions and collaborations with medical sleep centers. The management is optimistic about the potential for increased revenue generation from its innovative OSA appliances and related services, as it continues to adapt to changing market conditions and healthcare needs.